Search

everythinglearnresearchcommunity

for

Search:↓

In 2020, a new online survey was made to help identify Polycystic ovary syndrome (PCOS) in women, but it needs some improvements for better understanding and accuracy.

Single-spin PRP may be more effective for hair loss, but more research is needed.

The right balance of Myo-Inositol to D-Chiro-Inositol in follicular fluid is crucial for good egg and embryo quality.

PRP shows promise in treating urological diseases but needs more research.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Computational methods help design drugs targeting prostate cancer proteins.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Obesity and BMI don't differ among PCOS types, but teens should learn about long-term health risks.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

150 kHz electromagnetic radiation may improve polycystic ovary condition in rats.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Polycystic ovaries and early male baldness are inherited traits.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

The article concludes that PRP might help with hair loss, but more detailed research is necessary.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

PRP treatment can safely improve short-term vision in acute NAION patients.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Combining microfocused ultrasound with PRP-therapy improves skin quality and patient satisfaction more than ultrasound alone.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.